Citadel Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.46M Buy
147,800
+112,700
+321% +$2.04M ﹤0.01% 4984
2025
Q4
$498K Buy
35,100
+18,000
+105% +$341K ﹤0.01% 9024
2025
Q3
$423K Sell
17,100
-10,200
-37% -$228K ﹤0.01% 9537
2025
Q2
$619K Buy
27,300
+9,500
+53% +$225K ﹤0.01% 8127
2025
Q1
$540K Sell
17,800
-5,800
-25% -$221K ﹤0.01% 8305
2024
Q4
$936K Sell
23,600
-66,100
-74% -$2.98M ﹤0.01% 7164
2024
Q3
$5.69M Buy
89,700
+69,300
+340% +$5M ﹤0.01% 3748
2024
Q2
$1.38M Buy
20,400
+1,800
+10% +$126K ﹤0.01% 6006
2024
Q1
$1.47M Sell
18,600
-7,400
-28% -$605K ﹤0.01% 6123
2023
Q4
$2.02M Buy
26,000
+2,200
+9% +$163K ﹤0.01% 5329
2023
Q3
$1.67M Buy
23,800
+4,100
+21% +$306K ﹤0.01% 5544
2023
Q2
$1.57M Sell
19,700
-3,100
-14% -$224K ﹤0.01% 5606
2023
Q1
$1.65M Buy
22,800
+17,900
+365% +$1.4M ﹤0.01% 5737
2022
Q4
$403K Sell
4,900
-8,900
-64% -$734K ﹤0.01% 8697
2022
Q3
$1.08M Buy
+13,800
New +$1.1M ﹤0.01% 6842
2022
Q2
Sell
-12,600
Closed -$826K 12764
2022
Q1
$826K Sell
12,600
-3,100
-20% -$180K ﹤0.01% 8147
2021
Q4
$953K Buy
15,700
+9,300
+145% +$555K ﹤0.01% 8098
2021
Q3
$408K Buy
+6,400
New +$404K ﹤0.01% 10360
2021
Q2
Sell
-111,100
Closed -$6.35M 13574
2021
Q1
$6.35M Buy
111,100
+59,900
+117% +$3.24M ﹤0.01% 3772
2020
Q4
$2.57M Buy
+51,200
New +$2.04M ﹤0.01% 4840
2020
Q3
Sell
-11,700
Closed -$294K 9992
2020
Q2
$294K Sell
11,700
-1,300
-10% -$32.4K ﹤0.01% 7931
2020
Q1
$239K Buy
13,000
+6,600
+103% +$189K ﹤0.01% 7708
2019
Q4
$213K Sell
6,400
-12,400
-66% -$389K ﹤0.01% 8074
2019
Q3
$584K Sell
18,800
-16,900
-47% -$515K ﹤0.01% 6495
2019
Q2
$1.25M Sell
35,700
-18,300
-34% -$592K ﹤0.01% 5332
2019
Q1
$1.58M Buy
54,000
+13,900
+35% +$394K ﹤0.01% 4843
2018
Q4
$1.03M Sell
40,100
-4,100
-9% -$142K ﹤0.01% 5255
2018
Q3
$1.56M Buy
44,200
+30,600
+225% +$1.22M ﹤0.01% 4812
2018
Q2
$556K Buy
13,600
+6,400
+89% +$258K ﹤0.01% 6194
2018
Q1
$282K Sell
7,200
-4,900
-40% -$180K ﹤0.01% 6846
2017
Q4
$395K Buy
+12,100
New +$419K ﹤0.01% 6021
2017
Q2
Sell
-10,200
Closed -$445K 7402
2017
Q1
$445K Sell
10,200
-4,000
-28% -$162K ﹤0.01% 5217
2016
Q4
$470K Buy
14,200
+600
+4% +$23.3K ﹤0.01% 4997
2016
Q3
$674K Buy
13,600
+900
+7% +$46.9K ﹤0.01% 4392
2016
Q2
$704K Sell
12,700
-8,200
-39% -$480K ﹤0.01% 4021
2016
Q1
$1.15M Buy
20,900
+6,500
+45% +$371K ﹤0.01% 3313
2015
Q4
$899K Sell
14,400
-10,400
-42% -$677K ﹤0.01% 3707
2015
Q3
$1.64M Buy
24,800
+11,100
+81% +$854K ﹤0.01% 3193
2015
Q2
$1.07M Buy
13,700
+13,100
+2,183% +$943K ﹤0.01% 3873
2015
Q1
$43K Sell
600
-4,300
-88% -$276K ﹤0.01% 7467
2014
Q4
$300K Buy
4,900
+3,200
+188% +$186K ﹤0.01% 5425
2014
Q3
$82K Buy
1,700
+500
+42% +$24.4K ﹤0.01% 6571
2014
Q2
$55K Buy
+1,200
New +$52.7K ﹤0.01% 6687

Other funds holding ACHC

Citadel Advisors's ACHC Position: Q1 2026 in Review

Citadel Advisors increased its Acadia Healthcare (ACHC) stake by 100% in Q1 2026, buying an estimated $24.6M and bringing the position to 2,716,425 shares worth $63.5M. The position accounts for 0.01% of the portfolio, ranked #1145.

Citadel Advisors first reported a position in ACHC in Q3 2013 and has held it in 49 quarters since. The position peaked at $161M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Citadel Advisors held 2,716,425 shares of Acadia Healthcare worth $63.5M as of Q1 2026.
  • Citadel Advisors bought 1,361,142 Acadia Healthcare shares in Q1 2026, an estimated $24.6M.
  • Acadia Healthcare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1145 holding.
  • Citadel Advisors first reported a position in Acadia Healthcare in Q3 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Acadia Healthcare position peaked at $161M in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.